2-(2-Acetylamino-3-methyl-butyrylamino)-pentanedioic acid diamide

ID: ALA106812

Chembl Id: CHEMBL106812

PubChem CID: 14999599

Max Phase: Preclinical

Molecular Formula: C12H22N4O4

Molecular Weight: 286.33

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  CC(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(N)=O)C(C)C

Standard InChI:  InChI=1S/C12H22N4O4/c1-6(2)10(15-7(3)17)12(20)16-8(11(14)19)4-5-9(13)18/h6,8,10H,4-5H2,1-3H3,(H2,13,18)(H2,14,19)(H,15,17)(H,16,20)/t8-,10-/m0/s1

Standard InChI Key:  KJSDQSHAQAOEGG-WPRPVWTQSA-N

Associated Targets(non-human)

Kallikrein 1 (28 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 286.33Molecular Weight (Monoisotopic): 286.1641AlogP: -1.62#Rotatable Bonds: 8
Polar Surface Area: 144.38Molecular Species: NEUTRALHBA: 4HBD: 4
#RO5 Violations: 0HBA (Lipinski): 8HBD (Lipinski): 6#RO5 Violations (Lipinski): 1
CX Acidic pKa: 12.30CX Basic pKa: CX LogP: -2.38CX LogD: -2.38
Aromatic Rings: 0Heavy Atoms: 20QED Weighted: 0.42Np Likeness Score: -0.18

References

1. Deshpande MS, Burton J..  (1992)  Mapping the binding site of tissue kallikrein: preparation and testing of all possible substrate analog inhibitors homologous with the sequence of kininogen between Ser386 and Gln392.,  35  (17): [PMID:1507198] [10.1021/jm00095a002]

Source